These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
4. Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease patients with renal anemia: a retrospective study. Odajima K; Arai S; Kido R; Anzai H; Gojo M; Taira S; Matsui R; Fujigaki Y; Shibata S BMC Nephrol; 2024 Nov; 25(1):423. PubMed ID: 39587465 [TBL] [Abstract][Full Text] [Related]
5. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults. Huang Y; Trollor JN; Foley KR; Arnold SRC Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney disease. Haase VH; Tanaka T; Koury MJ Hematology Am Soc Hematol Educ Program; 2024 Dec; 2024(1):409-418. PubMed ID: 39644030 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of hypoxia-inducible factor-prolyl hydroxylation protects from cyclophosphamide-induced bladder injury and urinary dysfunction. Clayton DB; Tong CMC; Li B; Taylor AS; De S; Mason MD; Dudley AG; Davidoff O; Kobayashi H; Haase VH Am J Physiol Renal Physiol; 2022 Jul; 323(1):F81-F91. PubMed ID: 35499237 [TBL] [Abstract][Full Text] [Related]
8. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults. Love AMA; Edwards C; Cai RY; Gibbs V Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
10. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
11. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review. O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303 [TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells. Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527 [TBL] [Abstract][Full Text] [Related]
13. Interventions to improve mental health and well-being in care-experienced children and young people aged less than 25: the CHIMES systematic review. Evans R; MacDonald S; Trubey R; Noyes J; Robling M; Willis S; Vinnicombe S; Boffey M; Wooders C; El-Banna A; Melendez-Torres GJ Public Health Res (Southampt); 2024 Dec; 12(14):1-124. PubMed ID: 39641478 [TBL] [Abstract][Full Text] [Related]
14. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
15. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers. McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288 [TBL] [Abstract][Full Text] [Related]
16. Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148 [TBL] [Abstract][Full Text] [Related]
18. Public engagement to refine a whole-school intervention to promote adolescent mental health. Bonell C; Hope S; Sundaram N; Lloyd-Houldey O; Michalopoulou S; Scott S; Nicholls D; Viner R Public Health Res (Southampt); 2024 Dec; ():1-22. PubMed ID: 39636228 [TBL] [Abstract][Full Text] [Related]
19. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610 [TBL] [Abstract][Full Text] [Related]